Three distinct signals aligned on CRWV on Monday. Short interest jumped, put buying spiked, and the stock fell 5.6%. The convergence tells a consistent story: bearish pressure is building on CoreWeave.
SI hit 17.9% of the free float on June 22. That's up 13.9% in a single week and 14.3% over the past month. Since the prior ORTEX note on June 17 — when SI was at 16% — shorts have added another 7.4 million shares.
The prior article noted shorts were adding into a 19% rally. They kept adding as the stock reversed. That persistence stands out.
Borrow availability sits at 320% — still well within normal range, meaning roughly three shares remain available for every one already borrowed. There is no friction stopping new shorts from entering.
The put/call ratio hit 0.88 on Monday. That's 2.97 standard deviations above its 20-day mean of 0.78. The last time the PCR ran this far above its recent average, the stock had just posted a significant move. Monday's 5.6% drop appears to have driven fresh demand for downside protection.
The 52-week PCR range runs from 0.56 to 1.85, so current levels are elevated but not extreme on that longer horizon. Still, the z-score is the highest single-day reading in the past 30 days.
Analysts remain split. Cantor Fitzgerald reiterates Overweight at $167. BNP Paribas initiated at Outperform with a $192 target in early June. Against a current price of $111.29, those targets imply substantial upside.
Yet DA Davidson downgraded to Neutral in May, cutting its target from $175 to $100. JP Morgan holds Neutral at $105. The stock sits roughly at the midpoint of the neutral-camp targets — neither obviously cheap nor obviously rich.
The ORTEX short score is 57.4. It has climbed steadily from 54.0 two weeks ago. That drift reflects the accumulating bearish signals rather than any single trigger.
Founder and Chief Strategy Officer Brian Venturo sold roughly $6.1 million in shares on June 17, the day before the stock began sliding. The trades carry low individual significance scores, consistent with a pre-planned programme, but the timing adds context.
Next earnings are scheduled for August 6.
See the live data behind this article on ORTEX.
Open CRWV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
